Porcine islet cells of Langerhans are destroyed by human complement and not by antibody-dependent cell-mediated mechanisms

Transplantation

Volumn 62, Issue 1, 1996, Pages 29-33

  Schaapherder, Alexander F M ^a   Wolvekamp, Monique C J ^a   Te Bulte, Marie Thérése J W ^a   Bouwman, Eelco ^a   Gooszen, Hein G ^a   Daha, Mohamed R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGAMMAGLOBULINEMIA; ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; DIABETES MELLITUS; EFFECTOR CELL; GRAFT REJECTION; HUMORAL IMMUNITY; LANGERHANS CELL; MONONUCLEAR CELL; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELLS, CULTURED; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISLETS OF LANGERHANS TRANSPLANTATION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029893289     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607150-00006     Document Type: Article

References (39)

1. Robertson RP. Pancreas transplantation in humans with diabetes mellitus. Diabetes 1991; 40: 1085.
2. Scharp DW, Lacy PE, Santiago JV, et al. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation 1991; 51: 76.
3. Socci C, Falqui L, Davalli AM, et al. Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients: report of six cases. Acta Diabetol 1991; 28: 151.
4. Ricordi C, Tzakis AG, Carroll PB, et al. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 1992; 53: 407.
5. Crowther NJ, Gotfredsen CF, Moody AJ, Green IC. Immunological and insulin studies on isolated porcine islets of Langerhans. J Endocrinol 1990; 126: 43.
6. Marchetti P, Finke EH, Gerasimidi Vazeou A, Falqui L, Scharp DW, Lacy PE. Automated large-scale isolation, in vitro function and xenotransplantation of porcine islets of Langerhans. Transplantation 1991; 52: 209.
7. Calne RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 2: 550.
8. Auchincloss H Jr. Xenogeneic transplantation [Review]. Transplantation 1988; 46: 1.
9. Ricordi C, Lacy PE. Renal subcapsular xenotransplantation of purified porcine islets. Transplantation 1987; 44: 721.
10. Bandlien KO, Toledo Pereyra LH, Gordon DA. Islet cell allo- and xenotransplantation: effect of collagenase-free processing and renal subcapsular site. Transplant Proc 1987; 19: 2362.
11. Morel P, Kaufman DB, Platt J, et al. Islet xenotransplantation in a pre-clinical large animal model. Transplant Proc 1991; 23: 875.
12. Hamelmann W, Gray DW, Cairns TD, et al. Immediate destruction of xenogeneic islets in a primate model. Transplantation 1994; 58: 1109.
13. Schaapherder AFM, Daha MR, van der Woude FJ, Bruijn JA, Gooszen HG. IgM, IgG, and IgA antibodies in human sera directed against porcine islets of Langerhans. Transplantation 1993; 56: 1576.
14. Inverardi L, Pardi R. Humoral and cellular recognition of discordant xenogeneic Langerhans islets. Transplant Proc 1994; 26: 1034.
15. Mayer MM. Complement and complement fixation. In: Kabat EA, Mayer MM, eds. Experimental immunochemistry. Springfield: Thomas, 1961: 133
16. Roord JJ, Daha MR, Kuis W, et al. Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family. Pediatrics 1983; 71: 81.
17. Gaither TA, Ailing DW, Frank MM. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. J Immunol 1974; 113: 574.
18. Ono J, Takaki R, Fukuma M. Preparation of single cells from pancreatic islets of adult rat by the use of dispase. Endocrinol Jpn 1977; 24: 265.
19. Schaapherder AFM, Daha MR, te Bulte MTJW, van der Woude FJ, Gooszen HG. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57: 1376.
20. Ryan US, Maxwell G. Isolation, culture, and subculture of bovine pulmonary artery endothelial cells: mechanical methods. J Tissue Cult Methods 1986; 10: 3.
21. Sai P, Maurel C. Enzyme-linked immunosorbent assay for quantitation of islet cell antibodies. J Immunol Methods 1983; 64: 189.
22. Schaapherder AFM, Gooszen HG, te Bulte MTJW, Daha MR. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies. Transplantation 1995; 60: 287.
23. Horwitz DA, Bakke AC. An Fc receptor-bearing, third population of human mononuclear cells with cytotoxic and regulatory function. Immunol Today 1984; 5: 148.
24. Charles MA, Suzuki M, Waldeck N, et al. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. J Immunol 1983; 130: 1189.
25. Kohler E, Knospe S, Woltanski G, et al. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk. Biomed Biochim Acta 1984; 43: 627.
26. Poumay Y, Leclercq-Smekens M, Grailly S, Degen A, Leloup R. Specific internalization of basal membrane domains containing the integrin α6β4 in dispase-detached cultured human keratinocytes. Eur J Cell Biol 1993; 60: 12.
27. Dmochowski M, Hashimoto T, Bhogal BS, et al. Concomitant occurrence of circulating IgA anti-intercellular and anti-basement membrane zone antibodies in autoimmune blistering diseases: immunofluorescence and immunoblot studies. J Dermatol 1993; 20: 131.
28. Kohnert KD, Hehmke B. Preparation of suspensions of pancreatic islet cells: a comparison of methods. J Biochem Biophys Methods 1986; 12: 81.
29. Hehmke B, Lucke S, Schroder D, Kloting I, Kohnert KD. Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density. Eur J Immunol 1990; 20: 1091.
30. Buhler L, Deng S, Andereggen E, Bubloz C, Rohner A, Morel P. Comparison of concordant and discordant xenografted islets of Langerhans rejection. Transplant Proc 1994; 26: 3453.
31. Kaufman DB, Platt JL, Rabe FL, Dunn DL, Bach FH, Sutherland DE. Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med 1990; 172: 291.
32. Pittman K, Henretta J, McFadden T, Thomas J, Thomas FT. Prevention of primary nonfunction of xenograft islets. Transplant Proc 1994; 26: 1141.
33. Pound JD, Walker MR. Membrane Fc receptors for IgG subclasses. In: Shakib F, ed. The human IgG subclasses: molecular analysis of structure, function and regulation. New York: Pergamon, 1990: 111.
34. Perloff PJ, Naji A, Barker CF. Islet sensitivity to humoral antibody. Surg Forum 1981; 32: 390.
35. Naji A, Reckard CR, Ziegler MM, Barker CF. Vulnerability of pancreatic islets to immune cells and serum. Surg Forum 1975; 26: 459.
36. Reckard CR, Stuart FP, Clayman JL, Buckingham F, Schulak JA. Differential susceptibility of segmental and isolated islet allografts of rat pancreas to rejection and enhancement. Transplant Proc 1981; 13: 819.
37. Nash JR, Peters M, Bell PRF. Comparative survival of pancreatic islets, heart, kidney, and skin allografts in rats, with and without enhancement. Transplantation 1977; 24: 70.
38. Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferongamma, tumor necrosis factor, lymphotoxin, and interleukin-1. Diabetes 1988; 37: 133.
39. Kaufman DB, Rabe FL, Platt JL, Dunn DL, Sutherland DER. Effect of host immunomodulation on the prevention of islet allograft primary nonfunction in a murine model. Transplant Proc 1992; 22: 857.